دورية أكاديمية
Anticoagulants: Major Advances Without Clear Consensus.
| العنوان: | Anticoagulants: Major Advances Without Clear Consensus. |
|---|---|
| المؤلفون: | Hohl, RJ |
| المصدر: | Clinical Pharmacology & Therapeutics; Aug2016, Vol. 100 Issue 2, p116-118, 3p |
| مصطلحات موضوعية: | CARDIOVASCULAR disease treatment, THROMBOSIS, ANTICOAGULANTS, WARFARIN, HEPARIN, DRUG utilization |
| مستخلص: | Therapeutics for thrombosis were discovered because of observations made nearly one hundred years ago. The mainstays of these treatments have been either heparin or warfarin, with the latter being preferred for long-term anticoagulation. In the last six years, newer agents with antigoagulant activities have been approved for clinical use. These agents have advantages and disadvantages over warfarin and consensus for their use is still being formed, as is the manner in which the more traditional agents, such as warfarin, should be used and monitored. [ABSTRACT FROM AUTHOR] |
| Copyright of Clinical Pharmacology & Therapeutics is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| قاعدة البيانات: | Complementary Index |
Full Text Finder كن أول من يترك تعليقا!